DAVITA INC. Restricted Cash and Cash Equivalents
DAVITA INC. (DVA) had Restricted Cash and Cash Equivalents of $82.89 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-04
- 2026-06-30: Restricted Cash and Cash Equivalents $82.89M.
- 2026-03-31: Restricted Cash and Cash Equivalents $82.16M.
- 2025-12-31: Restricted Cash and Cash Equivalents $81.31M.
- 2025-09-30: Restricted Cash and Cash Equivalents $89.45M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2026-06-30 | $82.89M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $82.16M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $81.31M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $89.45M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $88.54M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $85.79M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $84.89M 10-K · filed 2026-02-11 |
| 2024-09-30 | $87.87M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $86.75M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $85.65M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $84.57M 10-K · filed 2025-02-13 |
| 2023-09-30 | $95.67M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $94.73M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $94.27M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $94.90M 10-K · filed 2024-02-14 |
| 2022-09-30 | $94.70M 10-Q · filed 2022-10-31 |
| 2022-06-30 | $93.13M 10-Q · filed 2022-08-01 |
| 2022-03-31 | $93.08M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $93.06M 10-K · filed 2023-02-22 |
| 2021-09-30 | $92.87M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $162.85M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $176.84M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $176.83M 10-K · filed 2022-02-11 |
| 2020-09-30 | $106.82M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $106.81M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $106.72M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $106.35M 10-K · filed 2021-02-12 |
| 2019-09-30 | $103.89M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $106.77M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $102.19M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $92.38M 10-K · filed 2020-02-21 |
| 2018-09-30 | $91.94M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $90.88M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $88.74M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $10.69M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |